Why Novo Nordisk Stock Sank 5.6% Today
25.11.25 00:48 Uhr
Werbung
Werte in diesem Artikel
Indizes
PKT PKT
1.773,1 PKT 46,3 PKT 2,68%
1.415,1 PKT 28,4 PKT 2,05%
2.709,6 PKT 26,7 PKT 1,00%
5.127,8 PKT -1,9 PKT -0,04%
Shares of Novo Nordisk (NYSE: NVO) fell on Monday, finishing down 5.6%. The drop comes as the S&P 500 and the Nasdaq Composite gained 1.5% and 2.6%, respectively. The Danish drugmaker's stock slumped after the company announced that a Phase II trial had failed to show positive results.Novo had been testing whether semaglutide, the key ingredient in its blockbuster diabetes and weight loss drugs, could be used to treat Alzheimer's disease. Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Quelle: MotleyFool
